FundedIQ
Biotechnology

Zenas BioPharma: Funding, Investors & Team (Oct 2026)

Zenas BioPharma is a company based in Florida, USA that specializes in creating immune-focused treatments for patients.

zenasbio.com LinkedIn Waltham, United States 51-100 employees
Biopharma Health Care Pharmaceutical
Total raised
$300M
Rounds
2
Latest
Undisclosed round
Mar 2026

Zenas BioPharma has raised $300M across 2 funding rounds on record, the most recent an undisclosed round of $100M announced in Mar 2026.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Zenas BioPharma Company Profile and Key Stats

Total funding raised
$300M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$100M in Mar 2026
Employees
51-100
reported band
Headquarters
Waltham, United States

Latest funding round on record: Mar 2026.

Zenas BioPharma Funding Rounds

Date
Round
Amount
Undisclosed round
$100M
Series C
$200M

Zenas BioPharma raised $200M in a Series C announced in May 2024.

1.8 years later, an undisclosed round of $100M was announced in Mar 2026.

Zenas BioPharma Founders and Leadership Team

Name
Role
Contact
Joe Farmer
Founder
Locked
Lonnie Moulder Jr
Founder
Locked

Contact details for the Zenas BioPharma team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

Zenas BioPharma Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Zenas BioPharma's latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Zenas BioPharma in Biotechnology and Waltham

Companies Similar to Zenas BioPharma

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Zenas BioPharma Funding FAQs

What does Zenas BioPharma do?

Zenas BioPharma is a company based in Florida, USA that specializes in creating immune-focused treatments for patients.

How much funding has Zenas BioPharma raised?

Zenas BioPharma has raised $300M across 2 rounds on record. The most recent is an undisclosed round of $100M announced in Mar 2026.

When did Zenas BioPharma last raise funding?

Zenas BioPharma's most recent funding round on record is an undisclosed round of $100M, announced in Mar 2026.

Who founded Zenas BioPharma?

FundedIQ lists Joe Farmer (Founder), Lonnie Moulder Jr (Founder) at Zenas BioPharma.

Where is Zenas BioPharma headquartered?

Zenas BioPharma is based in Waltham, Massachusetts, United States.

How many employees does Zenas BioPharma have?

Zenas BioPharma is in the 51-100 employee band.

How does Zenas BioPharma's funding compare to other Biotechnology startups?

Zenas BioPharma's latest round of $100M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Zenas BioPharma Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zenas BioPharma is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.